샘플 요청 목록

 카트 문의
시장보고서
상품코드
2148209

컴퓨터 보조 검출(CAD) 시장

Computer Aided Detection (CAD)
발행일: | 리서치사: 구분자 Market Glass, Inc. | 페이지 정보: 영문 364 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 파일 내 텍스트의 복사 및 붙여넣기는 가능하지만, 표/그래프 등은 복사할 수 없습니다. 인쇄는 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 5,850 금액 안내 화살표 ￦ 7,953,000
PDF & Excel (Team License: Up to 10 users) help
PDF & Excel 보고서를 동일 기업 내 최대 10명까지 이용할 수 있는 라이선스입니다. 파일 내 텍스트의 복사 및 붙여넣기가 가능하지만, 표/그래프 등은 복사할 수 없습니다. 인쇄는 이용자 1명당 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 11,115 금액 안내 화살표 ￦ 15,110,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel 보고서를 동일 기업 및 100% 자회사의 모든 분이 이용하실 수 있는 라이선스입니다. 인쇄는 1인당 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 17,550 금액 안내 화살표 ￦ 23,859,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 컴퓨터 보조 검출(CAD) 시장은 2032년까지 13억 달러에 달할 전망

2025년에 9억 5,570만 달러로 추정되는 세계의 컴퓨터 보조 검출(CAD) 시장은 2025년부터 2032년까지의 분석 기간 동안 CAGR 4.0%로 성장하여, 2032년까지 13억 달러에 달할 것으로 예상됩니다. 이 보고서에서 분석 대상이 되고 있는 부문 중 하나인 X선 영상 진단은 CAGR 3.6%를 기록하며 분석 기간 종료시점까지 3억 2,360만 달러에 달할 것으로 예상됩니다. 컴퓨터 단층촬영(CT) 진단 부문의 성장률은 분석 기간 중 CAGR 5.0%로 추정됩니다.

미국 시장은 2억 6,040만 달러로 추정되는 한편 중국은 CAGR 6.9%로 성장할 것으로 예측

미국의 컴퓨터 보조 검출(CAD) 시장은 2025년에 2억 6,040만 달러로 추산됩니다. 세계 2위의 경제 규모를 자랑하는 중국은 2025년부터 2032년까지의 분석 기간 동안 CAGR 6.9%를 기록하며 2032년까지 시장 규모가 2억 5,580만 달러에 달할 것으로 예측됩니다. 기타 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안에 각각 CAGR 1.9% 및 3.2%로 성장할 것으로 예측됩니다. 유럽내에서는 독일이 CAGR 약 2.5%로 성장할 것으로 예측됩니다.

세계의 컴퓨터 보조 검출(CAD) 시장 - 주요 동향과 촉진요인 개요

고급 알고리즘과 기계 학습을 활용한 컴퓨터 보조 검출(CAD) 시스템은 의료 영상 해석 및 다양한 의료 분야에서 진단 정확도 향상에 매우 중요한 역할을 하고 있습니다. 이러한 시스템은 X선, MRI, 내시경 검사, 초음파 검사 영상에서 잠재적인 이상을 식별함으로써 방사선과 의사를 지원하고, 필수적인 진단 지원을 제공합니다. 인공지능(AI)과 같은 첨단 기술이 통합됨에 따라 CAD 시스템은 디지털 병리학, 예방 검진, 응급 진단 등의 분야에서 점점 더 필수적인 요소가 되고 있습니다. 이러한 시스템에 대한 수요가 증가하는 배경에는, 특히 암과 같은 복잡한 분야에서 조기 발견과 정확한 진단을 지원함으로써 환자의 예후를 개선할 수 있는 능력이 있습니다.

유방촬영술(맘모그래피)이나 MRI와 같은 의료 영상 기술의 발전과 암 발병률의 증가가 CAD 시장의 주요 성장 촉진요인이 되고 있습니다. 이러한 기술 발전으로 인해 더욱 정밀하고 고해상도의 영상을 얻을 수 있게 되었으며, CAD 소프트웨어를 통한 분석의 정확도도 향상되고 있습니다. 또한, 의료 분야의 클라우드 컴퓨팅 전환을 통해 IT 비용 절감과 의료 종사자 간의 협업 강화를 실현하는, 확장성이 높고 사용하기 쉬운 CAD 솔루션의 개발이 가능해졌습니다. 다양한 진단 기기에서 얻은 영상을 분석할 수 있는 멀티모달리티 CAD 시스템의 동향은 진단 정확도와 환자의 예후를 더욱 향상시키고 있습니다.

CAD 시스템에 AI를 통합하는 것은 의료 영상 진단 분야의 중요한 진화를 상징하며, 방대한 데이터세트를 통해 학습하여 암 등의 질환을 나타내는 복잡한 패턴이나 이상을 인식하는 도구를 제공하고 있습니다. 이러한 AI 통합을 통해 진단이 신속해지고 인적 오류가 감소하며, 예방 의료와 조기 진단에 대한 중요성이 높아지고 있는 현 상황과 부합합니다. 일반적인 영상 진단에 그치지 않고, CAD 시스템은 대장내시경 검사에서의 용종이나 호흡기 내과에서의 폐 결절 탐지 등 전문적인 용도로도 활용되고 있습니다. CAD의 혁신은 디지털 병리학 분야에서도 진전을 보이고 있으며, 현재 진행 중인 연구에 따르면 그 적용 범위는 면역염색에 그치지 않고 표준 H&E 염색 분석과 같은 보다 광범위한 진단 업무로까지 확대되고 있어, 향후 의료 실무에 큰 영향을 미칠 가능성을 여실히 보여주고 있습니다.

부문 :

적응증(X선 영상 진단, 컴퓨터 단층촬영(CT), 초음파 영상 진단, 자기공명영상(MRI), 핵의학 영상 진단, 기타 적응증), 용도(결핵, 유방암, 폐암, 대장암, 전립선암, 간암, 골암, 기타 용도)

주요 기업

  • Agfa-Gevaert NV
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hitachi Ltd.
  • Hologic, Inc.
  • iCAD, Inc.
  • Invivo Corporation
  • Koninklijke Philips NV
  • McKesson Corporation
  • Merge Healthcare, Inc.
  • Siemens Healthineers

해당 분야의 전문가 관점을 바탕으로 함 - 산업계, 기업, 학계에 걸친 분야 전문가들의 관점을 반영하여, 기존에 발표된 조사 결과 이상의 맥락을 더하고 있습니다.

시장의 초기 신호를 포착 - 기존의 2차 조사에 완전히 반영되기 전에, 전문가 간의 대화, 기업의 동향, 시장과 관련된 논의를 통해 드러나는 변화를 추적합니다.

광범위하고 검증된 정보 기반을 활용 - 컨퍼런스 세션, 기조 연설, 패널 토론, 블로그, 기업의 공시 정보, 연차 보고서, 기관 간행물 및 기타 검증된 정보 출처에서 얻은 인사이트를 통합합니다.

신호와 전략적 시장 방향성을 연결 - 이러한 관점을 통합하여 시장이 어디로 향하고 있는지, 그 움직임을 주도하는 요인은 무엇인지, 그리고 전략에 있어 가장 중요할 가능성이 있는 동향은 무엇인지 파악합니다.

상세한 기업 정보를 제공 - 시장 수준의 분석에 그치지 않고, 경쟁 환경에 참여하며 그 형성에 기여하고 있는 기업을 면밀히 검토합니다.

주요 지역의 시장 점유율 분석 - 단일 세계 시장 점유율 수치만으로는 전체적인 상황을 파악하기 어렵습니다. 경쟁 구조는 지역에 따라 크게 다를 수 있습니다. 분석상 관련성이 있는 경우, Market Glass의 보고서에서는 각 시장의 구조와 동향에 맞춘 세부 수준으로 주요 지역의 시장 점유율 분석을 전개합니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 26.10.26

Global Computer Aided Detection (CAD) Market to Reach US$1.3 Billion by 2032

The global market for Computer Aided Detection (CAD) estimated at US$955.7 Million in the year 2025, is expected to reach US$1.3 Billion by 2032, growing at a CAGR of 4.0% over the analysis period 2025-2032. X-ray Imaging Indication, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$323.6 Million by the end of the analysis period. Growth in the Computed Tomography Indication segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$260.4 Million While China is Forecast to Grow at 6.9% CAGR

The Computer Aided Detection (CAD) market in the U.S. is estimated at US$260.4 Million in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$255.8 Million by the year 2032 trailing a CAGR of 6.9% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Computer Aided Detection (CAD) Market - Key Trends and Drivers Summarized

Computer-Aided Detection (CAD) systems, utilizing advanced algorithms and machine learning, play a crucial role in interpreting medical images and enhancing diagnostic accuracy across various medical fields. These systems assist radiologists by identifying potential abnormalities in images from X-rays, MRIs, endoscopies, and ultrasounds, providing vital diagnostic support. With the integration of sophisticated technologies such as artificial intelligence, CAD systems are becoming increasingly vital in fields like digital pathology, preventive screenings, and emergency diagnostics. The growing demand for these systems is driven by their ability to improve patient outcomes by supporting early detection and accurate diagnosis, particularly in complex areas such as cancer.

Technological advancements in medical imaging technologies such as mammography and MRI, coupled with the rising prevalence of cancer, are major drivers for the CAD market. These improvements lead to more precise and higher-resolution images, allowing CAD software to perform more accurate analyses. Additionally, the shift towards cloud computing in healthcare has enabled the development of scalable and accessible CAD solutions that offer reduced IT costs and enhanced collaboration among healthcare providers. The trend towards multi-modality CAD systems, capable of analyzing images from various diagnostic equipment, further enhances diagnostic accuracy and patient outcomes.

The integration of AI in CAD systems marks a significant evolution in medical imaging, providing tools that learn from vast datasets to recognize complex patterns and anomalies indicative of diseases such as cancer. This AI integration speeds up diagnostics and reduces human error, aligning with the increasing emphasis on preventative healthcare and early diagnosis. Beyond general imaging, CAD systems find specialized applications in detecting conditions such as polyps in colonoscopy and lung nodules in pulmonology. Innovations in CAD are also making headways into digital pathology, with ongoing research expanding its applications beyond immunostaining to include broader diagnostic tasks such as analyzing standard H&E stains, highlighting its potential to significantly impact future medical practices.

SCOPE OF STUDY:

The report analyzes the Computer Aided Detection (CAD) market by the following Segments, and Geographic Regions/Countries:

Segments:

Indication (X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication, Other Indications); Application (Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

  • Agfa-Gevaert NV
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hitachi Ltd.
  • Hologic, Inc.
  • iCAD, Inc.
  • Invivo Corporation
  • Koninklijke Philips NV
  • McKesson Corporation
  • Merge Healthcare, Inc.
  • Siemens Healthineers

WHAT SETS THIS REPORT APART FROM OTHERS?

Grounded in Domain Expert Perspectives - Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.

Captures Early Market Signals - Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.

Draws From a Broad, Validated Intelligence Base - Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.

Connects Signals With Strategic Market Direction - Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.

Provides In-Depth Company Intelligence - Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.

Market Share Is Examined Where It Matters - A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, Market Glass reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Computer Aided Detection (CAD) - Global Key Competitors Percentage Market Share in 2026 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for 103 Players Worldwide in 2026 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Cancer Drives Computer Aided Detection Market Growth
    • Need for Early Disease Detection Spur Adoption of CAD
    • Integration of AI and Machine Learning in CAD Systems Throws Spotlight on Innovation
    • Expansion of Telemedicine and Remote Diagnostics Accelerates Market Growth
    • Increasing Demand for Automated Detection Solutions Drives Market Demand
    • Rising Investments in Cancer Research Expands Market Horizons
    • Growing Focus on Reducing Diagnostic Errors Spurs Adoption of CAD Systems
    • Increasing Use of CAD in Breast Cancer Screening Sustains Market Growth
    • Rising Demand for CAD in Lung Cancer Detection Here is the Story
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Computer Aided Detection (CAD) Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
    • TABLE 2: World Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 3: World Historic Review for Computer Aided Detection (CAD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 4: World 13-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
    • TABLE 5: World Recent Past, Current & Future Analysis for X-ray Imaging Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 6: World Historic Review for X-ray Imaging Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 7: World 13-Year Perspective for X-ray Imaging Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 8: World Recent Past, Current & Future Analysis for Computed Tomography Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 9: World Historic Review for Computed Tomography Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 10: World 13-Year Perspective for Computed Tomography Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 11: World Recent Past, Current & Future Analysis for Ultrasound Imaging Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 12: World Historic Review for Ultrasound Imaging Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 13: World 13-Year Perspective for Ultrasound Imaging Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 14: World Recent Past, Current & Future Analysis for Magnetic Resonance Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 15: World Historic Review for Magnetic Resonance Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 16: World 13-Year Perspective for Magnetic Resonance Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 17: World Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 18: World Historic Review for Nuclear Medicine Imaging Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 19: World 13-Year Perspective for Nuclear Medicine Imaging Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 21: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 22: World 13-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 23: World Recent Past, Current & Future Analysis for Tuberculosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 24: World Historic Review for Tuberculosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 25: World 13-Year Perspective for Tuberculosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 26: World Recent Past, Current & Future Analysis for Breast Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 27: World Historic Review for Breast Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 28: World 13-Year Perspective for Breast Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 29: World Recent Past, Current & Future Analysis for Lung Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 30: World Historic Review for Lung Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 31: World 13-Year Perspective for Lung Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 32: World Recent Past, Current & Future Analysis for Colon Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 33: World Historic Review for Colon Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 34: World 13-Year Perspective for Colon Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 35: World Recent Past, Current & Future Analysis for Prostate Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 36: World Historic Review for Prostate Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 37: World 13-Year Perspective for Prostate Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 38: World Recent Past, Current & Future Analysis for Liver Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 39: World Historic Review for Liver Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 40: World 13-Year Perspective for Liver Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 41: World Recent Past, Current & Future Analysis for Bone Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 42: World Historic Review for Bone Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 43: World 13-Year Perspective for Bone Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 44: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 45: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 46: World 13-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032

III. MARKET ANALYSIS

  • UNITED STATES
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 48: USA Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 49: USA 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 50: USA Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 51: USA Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 52: USA 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 54: Canada Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 55: Canada 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 57: Canada Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 58: Canada 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • JAPAN
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 60: Japan Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 61: Japan 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 63: Japan Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 64: Japan 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • CHINA
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 66: China Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 67: China 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 68: China Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 69: China Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 70: China 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • EUROPE
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 72: Europe Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 73: Europe 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 75: Europe Historic Review for Computer Aided Detection (CAD) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 76: Europe 13-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 78: Europe Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 79: Europe 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • FRANCE
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 81: France Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 82: France 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 83: France Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 84: France Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 85: France 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • GERMANY
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 87: Germany Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 88: Germany 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 90: Germany Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 91: Germany 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 93: Italy Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 94: Italy 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 96: Italy Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 97: Italy 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • UNITED KINGDOM
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 99: UK Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 100: UK 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 101: UK Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 102: UK Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 103: UK 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • SPAIN
    • TABLE 104: Spain Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 105: Spain Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 106: Spain 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 107: Spain Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 108: Spain Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 109: Spain 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • RUSSIA
    • TABLE 110: Russia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 111: Russia Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 112: Russia 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 113: Russia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 114: Russia Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 115: Russia 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 118: Rest of Europe 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 121: Rest of Europe 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • ASIA-PACIFIC
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 124: Asia-Pacific 13-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 127: Asia-Pacific 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 130: Asia-Pacific 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
  • AUSTRALIA
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
    • TABLE 131: Australia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 132: Australia Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 133: Australia 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
    • TABLE 134: Australia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 135: Australia Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 136: Australia 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
  • INDIA
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
    • TABLE 137: India Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 138: India Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 139: India 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
    • TABLE 140: India Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 141: India Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 142: India 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
  • SOUTH KOREA
    • TABLE 143: South Korea Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 144: South Korea Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 145: South Korea 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
    • TABLE 146: South Korea Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 147: South Korea Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 148: South Korea 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
  • REST OF ASIA-PACIFIC
    • TABLE 149: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 150: Rest of Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 151: Rest of Asia-Pacific 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
    • TABLE 152: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 153: Rest of Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 154: Rest of Asia-Pacific 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
  • LATIN AMERICA
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 156: Latin America Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 157: Latin America 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 158: Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 159: Latin America Historic Review for Computer Aided Detection (CAD) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 160: Latin America 13-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
    • TABLE 161: Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 162: Latin America Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 163: Latin America 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • ARGENTINA
    • TABLE 164: Argentina Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 165: Argentina Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 166: Argentina 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 167: Argentina Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 168: Argentina Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 169: Argentina 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • BRAZIL
    • TABLE 170: Brazil Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 171: Brazil Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 172: Brazil 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 173: Brazil Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 174: Brazil Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 175: Brazil 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • MEXICO
    • TABLE 176: Mexico Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 177: Mexico Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 178: Mexico 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 179: Mexico Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 180: Mexico Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 181: Mexico 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • REST OF LATIN AMERICA
    • TABLE 182: Rest of Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 183: Rest of Latin America Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 184: Rest of Latin America 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 185: Rest of Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 186: Rest of Latin America Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 187: Rest of Latin America 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • MIDDLE EAST
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 189: Middle East Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 190: Middle East 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 191: Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 192: Middle East Historic Review for Computer Aided Detection (CAD) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 193: Middle East 13-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
    • TABLE 194: Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 195: Middle East Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 196: Middle East 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • IRAN
    • TABLE 197: Iran Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 198: Iran Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 199: Iran 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 200: Iran Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 201: Iran Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 202: Iran 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • ISRAEL
    • TABLE 203: Israel Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 204: Israel Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 205: Israel 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 206: Israel Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 207: Israel Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 208: Israel 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • SAUDI ARABIA
    • TABLE 209: Saudi Arabia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 210: Saudi Arabia Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 211: Saudi Arabia 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 212: Saudi Arabia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 213: Saudi Arabia Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 214: Saudi Arabia 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • UNITED ARAB EMIRATES
    • TABLE 215: UAE Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 216: UAE Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 217: UAE 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 218: UAE Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 219: UAE Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 220: UAE 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • REST OF MIDDLE EAST
    • TABLE 221: Rest of Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 222: Rest of Middle East Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 223: Rest of Middle East 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 224: Rest of Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 225: Rest of Middle East Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 226: Rest of Middle East 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032
  • AFRICA
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
    • TABLE 227: Africa Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 228: Africa Historic Review for Computer Aided Detection (CAD) by Application - Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 229: Africa 13-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Tuberculosis Application, Breast Cancer Application, Lung Cancer Application, Colon Cancer Application, Prostate Cancer Application, Liver Cancer Application, Bone Cancer Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 230: Africa Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 231: Africa Historic Review for Computer Aided Detection (CAD) by Indication - X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 232: Africa 13-Year Perspective for Computer Aided Detection (CAD) by Indication - Percentage Breakdown of Value Sales for X-ray Imaging Indication, Computed Tomography Indication, Ultrasound Imaging Indication, Magnetic Resonance Indication, Nuclear Medicine Imaging Indication and Other Indications for the Years 2020, 2026 & 2032

IV. COMPETITION

×

원하시는 정보를 찾아 드릴까요?

보안문자 새로고침
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기